Literature DB >> 8692881

Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice.

P J L'Huillier1, S Soulier, M G Stinnakre, L Lepourry, S R Davis, J C Mercier, J L Vilotte.   

Abstract

Transgenic mice carrying a bovine alpha-lactalbumin (alpha-lac) specific ribozyme gene under the transcriptional control of the mouse mammary tumor virus long terminal repeat were generated and cross-bred with animals that highly express a bovine alpha-lac transgene (0.4 mg of alpha-lac/ml(-1) of milk). The ribozyme contains the hammerhead catalytic domain, flanked by 12-nt sequences complementary to the 3' untranslated region of bovine alpha-lac transcript. High-level expression of the ribozyme gene was detected by Northern blot analysis in the mammary gland of 7-8 day lactating transgenic mice, from 3 of 12 lines analyzed. Heterozygous expression of the ribozyme resulted in a reduction in the levels of the target mRNA to 78, 58, and 50% of that observed in the nonribozyme transgenic littermate controls for three independent lines. The ribozyme-mediated reduction in the levels of the bovine protein paralleled that observed for the mRNA, and was positively correlated with the level of expression of the ribozyme. In nonribozyme expressing transgenic mice, the level of bovine alpha-lac mRNA and protein was not affected. The specificity of this activity is demonstrated by the absence of a reduction in the levels of the endogenous murine alpha-lac mRNA or protein. These results demonstrate the feasibility of ribozyme-mediated down-regulation of highly-expressed transcripts in transgenic animals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692881      PMCID: PMC39089          DOI: 10.1073/pnas.93.13.6698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Simple RNA enzymes with new and highly specific endoribonuclease activities.

Authors:  J Haseloff; W L Gerlach
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  A small catalytic oligoribonucleotide.

Authors:  O C Uhlenbeck
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

4.  Northern blot normalization with a 28S rRNA oligonucleotide probe.

Authors:  V Barbu; F Dautry
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Improved hybridization conditions for DNA 'fingerprints' probed with M13.

Authors:  D F Westneat; W A Noon; H K Reeve; C F Aquadro
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

7.  Ribozyme-mediated reversal of the multidrug-resistant phenotype.

Authors:  K J Scanlon; H Ishida; M Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Antisense RNA directed against the 3' noncoding region prevents dormant mRNA activation in mouse oocytes.

Authors:  S Strickland; J Huarte; D Belin; A Vassalli; R J Rickles; J D Vassalli
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

View more
  6 in total

Review 1.  Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies.

Authors:  J L Vilotte; P L'Huillier; J C Mercier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

Authors:  M M LaVail; D Yasumura; M T Matthes; K A Drenser; J G Flannery; A S Lewin; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Regulation of CAT protein by ribozyme and antisense mRNA in transgenic mice.

Authors:  D L Sokol; R J Passey; A G MacKinlay; J D Murray
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

Review 4.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

5.  Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model.

Authors:  M Andäng; J Hinkula; G Hotchkiss; S Larsson; S Britton; F Wong-Staal; B Wahren; L Ahrlund-Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Rescue of an MMTV transgene by co-integration reveals novel locus control properties of the ovine beta-lactoglobulin gene that confer locus commitment to heterogeneous tissues.

Authors:  B Langley; J L Vilotte; M G Stinnakre; C B Whitelaw; P J L'Huillier
Journal:  Transgenic Res       Date:  1998-05       Impact factor: 2.788

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.